Forest Laboratories and TransTech Pharma Enter Into License Agreement for the Development and Commercialization of Glucokinase Activators with Deal Valued at Up to $1.105 Billion 2010-06-08 News Release
TransTech Pharma and High Point Pharmaceuticals Awarded $1.96 million in Grants for Qualifying Therapeutic Development Projects 2010-11-04 News Release